# Phase 4 Pharmaceutical Llc – FDA Inspection, May 2, 2017

Source: https://www.keypedia.com/records/fda_inspections/phase-4-pharmaceutical-llc/d3ef30be-739a-4d9b-bb71-06523085f673
Source feed: FDA_Inspections

> FDA inspection 1010074 of Phase 4 Pharmaceutical Llc, May 02, 2017. Classification: Official Action Indicated (OAI). 6 citations under 21 CFR part 211. Form 483 issued. 1 other FDA inspection on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1010074
- Company Name: Phase 4 Pharmaceutical Llc
- Inspection Date: 2017-05-02
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: Unapproved and Misbranded Drugs
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 6

## Related Documents

- [FDA Inspection 950733 - 2015-12-15](https://www.keypedia.com/records/fda_inspections/phase-4-pharmaceutical-llc/b6752dd0-68fd-4e69-8bae-5144896f2108)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/joanne-e-king/39af2e60-385c-4023-a977-a25157b25563)

Company: https://www.keypedia.com/companies/phase-4-pharmaceutical-llc/c38543ce-01d5-494d-8d37-5ec2658ce067

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
